EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study

Yi Feng iD, Bo Cheng, Shuting Zhan, Haiping Liu, Jianfu Li, Peiling Chen, Zixun Wang, Xiaoyan Huang, Xiuxia Fu, Wenjun Ye, Runchen Wang, Qixia Wang und 9 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2024

DOI: 10.1007/s00259-024-06740-8 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Yi Feng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery and Oncology, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Di…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lung Neoplasms, Magnetic Resonance Imaging, Brain Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the China National Science Foundation, the Key Project of Guangzhou Scientific Research Project, the Science and Technology Planning Project of Guangzhou City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose [ 18 F]-FDG PET/CT and brain MRI are common approaches to detect metastasis in patients of lung cancer. Current guidelines for the use of PET/CT and MRI in clinical T1-category lung cancer lack risk-based stratification and require optimization. This study stratified patients based on metastatic risk in terms of the lesions' size and morphological characteristics.

Methods

The detection rate of metastasis was measured in different sizes and morphological characteristics (solid and sub-solid) of tumors. To confirm the cut-off value for discriminating metastasis and overall survival (OS) prediction, the receiver operating characteristic (ROC) analysis was performed based on PET/CT metabolic parameters (SUVmax/SUVmean/SULpeak/MTV/TLG), followed by Kaplan–Meier analysis for survival in post-operation patients with and without PET/CT plus MRI.

Results

2,298 patients were included. No metastasis was observed in patients with solid nodules < 8.0 mm and sub-solid nodules < 10.0 mm. The cut-off of PET/CT metabolic parameters on discriminating metastasis were 1.09 (SUVmax), 0.26 (SUVmean), 0.31 (SULpeak), 0.55 (MTV), and 0.81 (TLG), respectively. Patients undergoing PET/CT plus MRI exhibited longer OS compared to those who did not receive it in solid nodules ≥ 8.0 mm & sub-solid nodules ≥ 10.0 mm (HR, 0.44; p < 0.001); in solid nodules ≥ 8.0 mm (HR, 0.12; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLung NeoplasmsMagnetic Resonance ImagingBrain NeoplasmsHumansMaleFemaleMiddle AgedAgedCohort StudiesBrainAged, 80 and overAdultFluorodeoxyglucose F18

Stichwörter der Autor:innen

Brain MRIClinical T1-category Lung CancerMetastasisPET/CT

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Thoracic Surgery and Oncology, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University,…
  • Guangzhou Institute of Respiratory Health, Guangzhou, 510120, China.
  • PET/CT Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Nanshan School, Guangzhou Medical University, Jingxiu Road, Panyu District, Guangzhou, 511436, China.
  • The Radiology Department of the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
  • Detroit Medical Center Sinai-Grace Hospital, Internal Medicine Department, 6071 Outer Dr W, Detroit, MI, 48235, USA.

ORCID-Profile: Yi Feng

Förderung

  • the China National Science Foundation
  • the Key Project of Guangzhou Scientific Research Project
  • the Science and Technology Planning Project of Guangzhou City

Zitieren

APA

Feng, Y., Cheng, B., Zhan, S., Liu, H., Li, J., Chen, P., Wang, Z., Huang, X., Fu, X., Ye, W., Wang, R., Wang, Q., Xiang, Y., Wang, H., Zhu, F., Zheng, X., Fu, W., Hu, G., Chen, Z., …, & Liang, W. (2024). The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06740-8

Vancouver

Feng Y, Cheng B, Zhan S, Liu H, Li J, Chen P, et al. The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06740-8

BibTeX
@article{Feng2024,
  author = {Feng, Yi and Cheng, Bo and Zhan, Shuting and Liu, Haiping and Li, Jianfu and Chen, Peiling and Wang, Zixun and Huang, Xiaoyan and Fu, Xiuxia and Ye, Wenjun and Wang, Runchen and Wang, Qixia and Xiang, Yang and Wang, Huiting and Zhu, Feng and Zheng, Xin and Fu, Wenhai and Hu, Guodong and Chen, Zhuxing and He, Jianxing and Liang, Wenhua},
  title = {The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  doi = {10.1007/s00259-024-06740-8}
}
Kostenlos starten →